Article

Tumor mutational burden status and clinical characteristics of invasive lobular carcinoma of the breast

2025-04-10

Abstract excerpt

<title>Abstract</title> <p>Background High tumor mutational burden (TMB-H) is an established biomarker for a favorable response to immune checkpoint inhibitors. However, tumor mutational burden (TMB) in invasive ductal carcinoma (IDC) and invasive lobular carcinoma (ILC) has not been sufficiently investigated. Methods We collected data of patients with ILC or IDC from the Center for Cancer Genomics and Advanced...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9990a64c-5bf6-5c47-96c5-de85749ead1b
DOI: 10.21203/rs.3.rs-5578316/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Tumor mutational burden status and clinical characteristics of invasive lobular carcinoma of the breastDOI 10.21203/rs.3.rs-5578316/v1Read

Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.Semantic proximity Read

The Genomic Landscape of Lobular Breast CancerSemantic proximity Read

Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.Semantic proximity Read

The Predictive Effect of Tumor Mutation Burden on prognosis in Breast cancer: A Systematic Review and Meta-AnalysisSemantic proximity Read

Genomic Characterization of Primary Invasive Lobular Breast Cancer.Semantic proximity Read

Multi-omic characterization of ILC and ILC-like cell lines as part of ILC cell line encyclopedia (ICLE) defines new models to study potential biomarkers and explore therapeutic opportunitiesSemantic proximity Read

Clinicogenomic characterization of inflammatory breast cancerSemantic proximity Read

Prevalence and molecular features of TMB-high and MSI-high breast cancer assessed by gene panel testingSemantic proximity Read

Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer.Semantic proximity Read

High Tumor Mutation Burden and Other Immunotherapy Response Predictors in Breast Cancers: Associations and Therapeutic Opportunities.Semantic proximity Read

Tumor mutational and indel burden: a systematic pan-cancer evaluation as prognostic biomarkersSemantic proximity Read

Assessment of blood-based tumor mutational burden on clinical outcomes in advanced breast and prostate cancer treated with immune checkpoint inhibitorsSemantic proximity Read